Literature DB >> 12759328

Clinical trials--multiple treatments, multiple end points, and multiple lessons.

Michael S Lauer, Eric J Topol.   

Abstract

Mesh：

Year:  2003        PMID： 12759328     DOI： 10.1001/jama.289.19.2575

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  12 in total

1.  Can the ST segment be saved?

Authors:  Michael S Lauer
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

2.  Rosuvastatin in diabetic hemodialysis patients.

Authors:  Hallvard Holdaas; Ingar Holme; Roland E Schmieder; Alan G Jardine; Faiez Zannad; Gudrun E Norby; Bengt C Fellström
Journal:  J Am Soc Nephrol       Date:  2011-05-12       Impact factor: 10.121

3.  Prognostic Value of Coronary Artery Calcium in the PROMISE Study (Prospective Multicenter Imaging Study for Evaluation of Chest Pain).

Authors:  Matthew J Budoff; Thomas Mayrhofer; Maros Ferencik; Daniel Bittner; Kerry L Lee; Michael T Lu; Adrian Coles; James Jang; Mayil Krishnam; Pamela S Douglas; Udo Hoffmann
Journal:  Circulation       Date:  2017-08-28       Impact factor: 29.690

4.  Clinical trial design--effect of prone positioning on clinical outcomes in infants and children with acute respiratory distress syndrome.

Authors:  Martha A Q Curley; John H Arnold; John E Thompson; James C Fackler; Mary Jo Grant; Lori D Fineman; Natalie Cvijanovich; Frederick E Barr; Shirley Molitor-Kirsch; David M Steinhorn; Michael A Matthay; Patricia L Hibberd
Journal:  J Crit Care       Date:  2006-03       Impact factor: 3.425

5.  Rethinking composite end points in clinical trials: insights from patients and trialists.

Authors:  Joshua M Stolker; John A Spertus; David J Cohen; Philip G Jones; Kaushik K Jain; Emily Bamberger; Brady B Lonergan; Paul S Chan
Journal:  Circulation       Date:  2014-09-08       Impact factor: 29.690

6.  Efficacy and tolerability balance of oxycodone/naloxone and tapentadol in chronic low back pain with a neuropathic component: a blinded end point analysis of randomly selected routine data from 12-week prospective open-label observations.

Authors:  Michael A Ueberall; Gerhard H H Mueller-Schwefe
Journal:  J Pain Res       Date:  2016-11-11       Impact factor: 3.133

7.  Lung Cancer Care Before and After Medicare Eligibility.

Authors:  Marco D Huesch; Michael K Ong
Journal:  Inquiry       Date:  2016-05-10       Impact factor: 1.730

8.  Beyond the Primary Endpoint Paradigm: A Test of Intervention Effect in HIV Behavioral Intervention Trials with Numerous Correlated Outcomes.

Authors:  Jessica M Harwood; Robert E Weiss; W Scott Comulada
Journal:  Prev Sci       Date:  2017-07

9.  Are component endpoints equal? A preference study into the practice of composite endpoints in clinical trials.

Authors:  Melissa C W Vaanholt; Marlies M Kok; Clemens von Birgelen; Marieke G M Weernink; Janine A van Til
Journal:  Health Expect       Date:  2018-08-14       Impact factor: 3.377

Review 10.  Understanding the Use of Composite Endpoints in Clinical Trials.

Authors:  C Eric McCoy
Journal:  West J Emerg Med       Date:  2018-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.